Analytical Tool - Cancer Vaccines 'Analytical Tool - Cancer Vaccines' offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same... |
Analytical Tool: The Commercial Success of Cancer Therapeutic Antibodies "Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer.... |
Analytical Tool - Pancreatic Cancer 'Analytical Tool - Pancreatic Cancer' offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in pancreatic cancer R&D and business development. It is at... |
Monoclonal Antibodies, Vaccines and Other Immunologic Cancer Treatments World Market Cancer is the second most common cause of death in the industrialized world. At this time, treatment for cancer focuses on some combination of surgery, radiation, and chemotherapy. But... |
Analytical Tool Cancer Therapeutic Antibodies "Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer.... |
Analytical Tool - Colorectal Cancer 'Analytical Tool - Colorectal Cancer' offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development. It is at... |
Chinese Markets for Skin Cancer Treatment Drugs China's demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow.... |
Analytical Tool - Cancer Immunotherapy 'Analytical Tool - Cancer Immunotherapy' offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in immunotherapy drug development for the treatment of cancer. It... |
Analytical Tool - Targeted Therapeutics: Non-Small Cell Lung Cancer Non-Small Cell Lung Cancer "Analytical Tool - Targeted Therapeutics: Non-Small Cell Lung Cancer " offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in non-small cell lung cancer... |
Targeted Therapeutics in Non-Small Cell Lung Cancer Introduction
Lung cancer is the third most common malignant disease and the first leading cause of cancer death in the western world. Yet platinum agent constitutes the current mainstay of front-line... |
Leading Anti-Cancer Drugs World Market Prospects 2011-2021 What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data... |
Immunotherapies and Vaccines for Cancer and Infectious Diseases The field of therapeutic vaccines and immunotherapies is rapidly emerging as a promising area. Use of passive immunotherapy (i.e., antibody) products, for prevention of infection or for treatment of many... |
Chinese Markets for Kidney Cancer Treatment Drugs China's demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to... |
Analytical Tool - Current & Future Lung Cancer Therapeutics Introduction
Analytical Tool - Current & Future Lung Cancer Therapeutics is a premium combo product of "Current and Future Therapies for Lung Cancer: A Therapeutic & Competitive Insight" and "Lung Cancer... |
Analytical Tool - Breast Cancer 'Analytical Tool - Breast Cancer' offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at... |
Analytical Tool: Competitive Outlook on Cancer Vaccines "Analytical Tool - Cancer Vaccines" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in cancer vaccine drug development. It is at the same... |
Cancer Therapies: Technologies and Global Markets Study Objectives
Bcc's Goal In Conducting This Study Is To Provide An Overview Of The Current And Potential Aspects Of The Global Market For Cancer Therapies. The Report Determines The Market... |
Prostate Cancer: Vaccines and Therapeutic Antibodies 2011 The prostate cancer immunotherapy pipeline is showing rapid development. Currently, there are 30 candidates in the pipeline (16 vaccines and 14 therapeutic antibodies), and one prostate cancer vaccine (Provenge®) has... |
Analytical Tool - Prostate Cancer 'Analytical Tool - Prostate Cancer' offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in prostate cancer R&D and business development. It is at... |
Analytical Tool: Breast Cancer R&D Comprehensive Guide "Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at... |
Immunotherapy of Cancer Cancer immunotherapeutics, in particular monoclonal antibody-based products and vaccines, are transforming the cancer treatment market and providing a whole new arsenal of weapons. The introduction of the first monoclonal antibody... |
Cancer Cell Therapy Markets Traditionally, treatment of disease is carried out by small molecules that target specific cell types. In diseases such as cancer, the treatment is meant to kill cancer cells, leading to... |
Cytology and HPV Testing World Markets Cancer is a group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread is not controlled, it can result in death. Cancer is caused by... |
Cancer Therapeutics: The Worldwide Market The Worldwide Market , 2nd Editon This completely updated edition of this comprehensive and indispensable report covers the breadth of traditional IVD testing. The report contains complete market statistics and analysis for all areas of IVD,... |
Preclinical Cancer Therapeutics 2007 Decoding Next Generation Drug Targets for Market Success Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success is a unique and unrivalled 367-page report analysing the performance of numerous important early stage oncology drug candidates,... |